Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Adma Biologics, Inc.

NASDAQ: ADMA · Life Sciences · 5 alerts · CIK 1368514

Share price
$13.47Close, Nov 16
Market cap
$2.99B
Shares outstanding
221.85MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Adma Biologics, Inc. filings on SEC EDGAR ↗

9:06 PM ET Form 4
Insider Selling

Adma Biologics Director Lawrence P. Guiheen Sells $139K of Stock

Lawrence P. Guiheen, Director, sold 10,000 shares of Adma Biologics, Inc. at $13.92 a share, worth $139K in total on Nov 16, 2026. Shares held after the trade: 63,599 (-13.6%).

Value
$139K
Shares
10,000
Price
$13.92
Role
Director
Holding change
-13.6%
Trade date
Nov 16, 2026
9:02 PM ET Form 4
Insider Selling

Adma Biologics President and CEO Adam S. Grossman Sells $288K of Stock

Adam S. Grossman, President and CEO, sold 21,000 shares of Adma Biologics, Inc. at $13.72 a share, worth $288K in total on Nov 16, 2026. Shares held after the trade: 2,064,777 (-0.3%).

Value
$288K
Shares
21,000
Average price
$13.72
Role
President and CEO
Holding change
-0.3%
Trade date
Nov 16, 2026
9:05 PM ET Form 4
Insider Selling

Adma Biologics President and CEO Adam S. Grossman Sells $1.76M of Stock

Adam S. Grossman, President and CEO, sold 147,000 shares of Adma Biologics, Inc. at $12.00 a share, worth $1.76M in total on Nov 5, 2026. Shares held after the trade: 2,070,777 (-2.0%).

Value
$1.76M
Shares
147,000
Average price
$12.00
Role
President and CEO
Holding change
-2.0%
Trade date
Nov 5, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.